We serve Chemical Name:L-GLUTAMIC ACID γ-HYDRAZIDE CAS:1820-73-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:L-GLUTAMIC ACID γ-HYDRAZIDE
CAS.NO:1820-73-1
Synonyms:G-L-GLUTAMYL HYDRAZIDE;L-GLUTAMICACIDG-HYDRAZIDE;L-Glutaminsaeure-5-hydrazid;L-2-Amino-glutarsaeure-5-hydrazid;L-Glutamic acid 5-hydrazide
Molecular Formula:C5H11N3O3
Molecular Weight:161.15900
HS Code:2928000090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:478.1ºC at 760 mmHg
Density:1.35g/cm3
Index of Refraction:1.539
PSA:118.44000
Exact Mass:161.08000
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like G-L-GLUTAMYL HYDRAZIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Glutamic acid 5-hydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Glutaminsaeure-5-hydrazid Use and application,G-L-GLUTAMYL HYDRAZIDE technical grade,usp/ep/jp grade.
Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. L-GLUTAMIC ACID γ-HYDRAZIDE manufacturer One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. L-GLUTAMIC ACID γ-HYDRAZIDE supplier Thank you for being open” about the diagnosis, NBC’s chief foreign affairs correspondent and anchor Andrea Mitchell wrote to Amanpour on Twitter. “It is so important and typical of how strong and brave you’ve always been. Courage and honesty is your trademark. You will beat this too. L-GLUTAMIC ACID γ-HYDRAZIDE vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. L-GLUTAMIC ACID γ-HYDRAZIDE factory China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.
